Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies
A Zuddas, R Zanni, T Usala - European Neuropsychopharmacology, 2011 - Elsevier
In children and adolescents the Second Generation Antipsychotics (SGAs) represent the
class of psychotropic drugs whose use has grown more significantly in recent years: they are …
class of psychotropic drugs whose use has grown more significantly in recent years: they are …
The evidence-based choice for antipsychotics in children and adolescents should be guaranteed
D Putignano, A Clavenna, L Reale, M Bonati - European journal of clinical …, 2019 - Springer
Purpose Drug use in the pediatric population still often features off-label prescriptions,
particularly for psychotropic drugs. We reviewed the registration status, scientific evidence …
particularly for psychotropic drugs. We reviewed the registration status, scientific evidence …
Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009
KA Betts, V Sikirica, P Hodgkins, Z Zhou… - Journal of child and …, 2014 - liebertpub.com
Objective: Stimulants are recommended as a first-line treatment for attention-
deficit/hyperactivity disorder (ADHD); however, a subset of the patient population augments …
deficit/hyperactivity disorder (ADHD); however, a subset of the patient population augments …
[图书][B] The skeptical professional's guide to psychiatry: on the risks and benefits of antipsychotics, antidepressants, psychiatric diagnoses, and Neuromania
CE Dean - 2020 - taylorfrancis.com
This text critically examines the shortcomings of psychiatry; the flawed development of the
diagnostic system, including the DSM-5; and the failure to advance the effectiveness of …
diagnostic system, including the DSM-5; and the failure to advance the effectiveness of …